Location:Room 1, Capital suite (level 3)
The management of urological cancer in the elderly is a major public health problem due to the ageing population, increased cancer risk with age and therapeutic progress. Do we have to make a difference in treatments because of the patient’s age? Can you propose to seniors, for example a prostatectomy, nephrectomy, cystectomy or neo-adjuvant chemotherapy before cystectomy? Does the treatment depend on the age of the patient or on his general condition? Do we still have just to use the Charlson Index to evaluate if a patient can undergo a treatment. Do we have to use other instruments/validated questionnaires? What is the role of the nurse? These session will clarify this questions.
Age should not be the primary factor in oncology treatment decision-making for elderly persons. It remains a challenge to estimate the real benefit of a treatment for one individual, or to predict treatment tolerance and postoperative complications. Comprehensive Geriatric Assessment (CGA) may improve outcomes for vulnerable older patients with cancer.